3Vonderheide RH,Burg JM,Mick R. Phase Ⅰ study of the CD40 agonist antibody CP-870,893 combined with carboplatin and paclitaxel in patients with advanced solid tumors[J].Oncoimmunology,2013,(01):e23033.
4Gladue RP,Paradis T,Cole SH. The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu mice[J].{H}Cancer Immunology lmmunotherapy,2011,(07):1009-1017.
5Xu H,Zhao G,Huang X. CD40-expressing plasmid induces antiCD40 antibody and enhances immune responses to DNA vaccination[J].{H}Journal of Gene Medicine,2010,(01):97-106.
6Rycyzyn MA,Staquet K,Fisher J. The use of anti-CD40 agonist monoclonal antibody during immunizations enhances hybridoma generation[J].{H}HYBRIDOMA,2008,(01):25-30.
7Hunter TB,Alsarraj M,Gladue RP. An agonist antibody specific for CD40 induces dendritic cell maturation and promotes autologous anti-tumour T-cell responses in an in vitro mixed autologous tumour cell/lymph node cell model[J].{H}Scandinavian Journal of Immunology,2007,(05):479-486.
8Barr T,Carlring J,Heath A. Co-stimulatory agonists as immunological adjuvants[J].{H}VACCINE,2006,(17):3399-3407.doi:10.1016/j.vaccine.2006.02.022.
9Barr TA,McCormick AL,Carlring J. A potent adjuvant effect of CD40 antibody attached to antigen[J].{H}IMMUNOLOGY,2003,(01):87-92.
10Zhou ZH,Wang JF,Wang YD. An agonist anti-human CD40 monoclonal antibody that induces dendritic cell formation and maturation and inhibits proliferation of a myeloma cell line[J].{H}HYBRIDOMA,1999,(06):471-478.
